Developer docs
API playgroundTry for free, no card

Search company profiles

Karaiskakio Foundation

Full company profile

uuid000883n

Namestring
Karaiskakio Foundation
Legal namestring
Karaiskakio Foundation
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Karaiskakio Foundation is a Cyprus-based non-profit charitable organization founded in 1996 in memory of Andreas Karaiskakis, a 5-year-old who died of leukemia after a matching bone marrow donor could not be found. The Foundation operates the Cyprus Bone Marrow Donor Registry — recognized as the world's largest per capita with over 200,000 registered Greek-Cypriot and Turkish-Cypriot volunteer donors — along with the Public Rotary Cord Blood Registry (4,500+ stored units) and a network of four specialized diagnostic laboratories: an Immunogenetics Laboratory (continuously EFI-accredited since 2004), an eight-color Flow Cytometry Laboratory serving as Cyprus's central reference lab for hematological malignancies, a Molecular Haematology Laboratory, and a CytoGenomics Laboratory employing SKY-FISH and Microarray methodologies. The Foundation also runs the Center for the Study of Haematological Malignancies (CSHM/KEMAK, established 2008) as its research arm and the Care for Rare Clinic for pediatric genetic disorders, and it offers a Hair Donation Program in partnership with Wigs for Kids.

Services are delivered at no cost to patients; the Foundation funds donor search, tissue typing (€40 per new donor typing), and diagnostic testing through a diversified revenue model comprising individual donations, membership subscriptions (€20/year plus €10 registration), Cyprus Ministry of Health government sponsorship, corporate sponsorships via the 'Partnership 4 Life' CSR program, and fees from specialized diagnostic services. Distribution combines a hospital blood bank collection network across Cyprus, the global Bone Marrow Donors Worldwide (BMDW) integration (member since 2000), a Nicosia General Hospital on-site presence, and an online donor registration portal.

Operationally, the Foundation has facilitated over 950 bone marrow transplants across 36 countries and served 30,000+ patients with diagnostic tests. It is governed by an unpaid Board appointed by its co-founders (Cyprus Ministry of Health, Association of Friends of Karaiskakio Foundation, the Karaiskakis family, and the UK Leukemia Cancer Society), with a workforce of 11–50 employees based at its Nicosia headquarters.

Short descriptiontext

Karaiskakio Foundation is a Cyprus-based non-profit operating the world's largest per capita bone marrow donor registry (200,000+ donors), four EFI/WMDA-accredited diagnostic laboratories, a cord blood registry, and pediatric rare disease services, serving patients with hematological malignancies at no cost.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNicosia, Cyprus
HQ citystring
Nicosia
HQ countrystring
Cyprus
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bone marrow registry, hematology diagnostic services, cord blood banking, leukemia transplant support, rare disease genetics
Industry3 codes
PRIMARYBPAGACAJ
Blood, Organ & Tissue Donation Organizations
SECONDARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
NAICS code2 codes
  • Blood and Organ Banks621991
  • Voluntary Health Organizations813212
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Social Services8300
Product category
Non-profit Hematology and Bone Marrow Registry Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Donations and Contributions
TypeGrants Donations
Description

The Foundation relies heavily on donations from individuals, companies, and organizations. Donations can be general or for specific purposes (in memory of someone, in honor of celebrations, wedding/christening gifts, etc.). A donation of €40 can finance tissue typing of a new bone marrow donor volunteer.

karaiskakio.org.cy
2Membership Fees
TypeSubscription Recurring
Description

Annual membership subscription of €20 with a registration fee of €10 for new members. Members have voting rights and can be candidates for the Volunteer Member Council.

karaiskakio.org.cy
3Government Sponsorship
TypeGrants Donations
Description

Government sponsorship for support of the Cyprus Donor Registry. The Ministry of Health collaborates with the Foundation on various programs.

karaiskakio.org.cy
4Corporate Sponsorships (Partnership 4 Life)
TypeGrants Donations
Description

Corporate partnerships through the 'Partnership 4 Life' program where companies support the Foundation's mission as part of their Corporate Social Responsibility. Sponsors provide financial support in exchange for association with the Foundation's humanitarian work.

karaiskakio.org.cy
5Service Revenue
TypeOthers
Description

Income from provision of specialized diagnostic laboratory services. The Foundation aims to serve needs of patients with haematological malignancies efficiently and effectively without financial burden to patients or families.

karaiskakio.org.cy
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
Pricing details3 tiers
1Membership subscription
ModelSubscriptionBilling cadenceAnnual
Notes

Annual membership: €20. Registration fee: €10.

karaiskakio.org.cy
2Donor tissue typing sponsorship
ModelDonation/ grant-fundedBilling cadenceOne-time
Notes

A donation of €40 can finance the tissue typing of one new bone marrow donor volunteer. The Foundation aims to tissue type 5-10,000 volunteer donors annually.

karaiskakio.org.cy
3Fundraising event tickets
ModelOtherBilling cadenceOne-time
Notes

Dinner for Life charity event tickets: €80 per person

cyprus-mail.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Karaiskakio Foundation operates the Cyprus Bone Marrow Donor Registry — the world's largest per capita with over 200,000 registered donors — along with a Public Cord Blood Registry, four EFI/WMDA-accredited diagnostic laboratories (Immunogenetics, Flow Cytometry, Molecular Haematology, CytoGenomics), the Care for Rare Clinic for pediatric genetic disorders, and the CSHM research center. All donor search, tissue typing, and diagnostic services are provided to patients free of charge, funded by donations, government sponsorship, corporate partnerships, and membership fees.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Over 950 life-saving bone marrow transplants facilitated across 36 countries and 5 continents
+4 more records
Product overview1 text field

Karaiskakio Foundation is a non-profit organization operating as a comprehensive healthcare center focused on haematological malignancies and related diseases. The foundation operates its core services through the Cyprus Bone Marrow Donor Registry (one of the world's largest per capita registries with over 200,000 donors), the Cyprus Rotary Cord Blood Registry, and a network of four specialized diagnostic laboratories (Immunogenetics, Flow Cytometry, Molecular Haematology, and CytoGenomics). The foundation also conducts research through its Center for the Study of Haematological Malignancies (CSHM/KEMAK), operates the Care for Rare Clinic for pediatric genetic disorders, and offers community services including a hair donation program and online donation platform. Services are provided free of charge to patients, with the foundation covering all costs for donor searches and laboratory testing.

Product and service10 records
1Cyprus Bone Marrow Donor Registry
CategoryRegistry service
Description

Operates the world's largest per capita bone marrow donor registry with over 200,000 registered Greek Cypriot and Turkish Cypriot volunteer donors; accredited by WMDA since 2008 and connected to Bone Marrow Donors Worldwide. Facilitates donor searches for patients with leukemia and other hematological malignancies free of charge.

2Cyprus Rotary Cord Blood Registry
CategoryCord blood banking
Description

Public cord blood registry established in collaboration with the Cyprus Ministry of Health and ten Rotary Clubs, storing over 4,500 cord blood units as an alternative stem cell source for transplant patients. Currently focuses on directed and autologous donations as new public storage is no longer accepted.

3Immunogenetics Laboratory Services
CategoryDiagnostic laboratory service
Description

EFI-accredited laboratory since 2004 providing tissue typing and HLA compatibility testing for bone marrow donor matching. Provides state-of-the-art immunogenetics testing to support transplant matching for patients with hematological malignancies.

4Flow Cytometry Laboratory Services
CategoryDiagnostic laboratory service
Description

Eight-color flow cytometry laboratory serving as the central reference laboratory for hematological malignancies diagnostics in Cyprus. Responsible for diagnosis and monitoring of disease burden in leukemia, lymphoma, and other blood cancers.

5Molecular Haematology Laboratory Services
CategoryDiagnostic laboratory service
Description

Specialized molecular testing for detection of recurrent chromosomal aberrations and gene mutations affecting prognosis of leukemias. Includes thrombophilia and hemophilia tests, supporting detailed evaluation of therapy options and timely detection of disease relapse.

6CytoGenomics Laboratory Services
CategoryDiagnostic laboratory service
Description

Combines classical cytogenetics and modern cytogenomics methodologies including SKY-FISH and Microarray for studying hematological malignancies. Supports diagnosis, prognosis, and monitoring of blood cancers.

7Care for Rare Clinic
CategoryHealthcare service
Description

Integrated interdisciplinary centre for children and families with rare diseases and genetic disorders, providing holistic disease management and pediatric genetic testing services. Has supported more than 30,000 patients with specialized diagnostics.

8Hair Donation Program
CategoryCommunity support service
Description

Community program collecting hair donations in partnership with Wigs for Kids to support children who have lost their hair due to leukemia, cancer, or other disease treatments.

9Online Donation Platform
CategoryDonation service
Description

Digital donation platform enabling individuals and organizations to contribute financially to support the Foundation's activities and patient services. A donation of €40 can finance the tissue typing of one new bone marrow donor volunteer.

10Center for the Study of Haematological Malignancies (CSHM/KEMAK)
CategoryResearch service
Description

Non-profit research arm of the Foundation established in 2008, conducting studies on hematological malignancies in collaboration with University of Cyprus, University of Cambridge, University of Surrey, University of Athens, and University of Patras.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership19 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-14
Description

Allwyn Cyprus unveiled the 'Allwyn Care' healthcare initiative in collaboration with Karaiskakio Foundation and other healthcare organizations including PASYKAF, Europa Donna Cyprus, and Europa Uomo Cyprus. The program supports cancer awareness, early diagnosis, bone marrow donor registry development, and palliative care services, reaching over 250,000 people through awareness campaigns.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-07
Description

Eurolife and Karaiskakio Foundation formalized a strategic partnership aimed at strengthening the Foundation's research and educational work while promoting volunteerism and social contribution among Cyprus' younger generation. The collaboration falls within Eurolife's Corporate Social Responsibility framework, reflecting shared values of supporting life, health, and hope.

3Lexus Cycling Dream Team
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-10-20
Description

The Lexus Cycling Dream Team, a group of Cypriot business executives passionate about cycling and philanthropy, organized the 'Ride of Love 2025' charity cycling event covering 175 kilometers across Cyprus, supporting the Childhood Cancer Diagnostic and Investigation Centre of the Karaiskakio Foundation.

cyprus-mail.com
4KINTO Europe
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-10-20
Description

KINTO Europe (Toyota Motor Europe's subsidiary) served as Mobility Partner for the 'Ride of Love 2025' cycling event supporting Karaiskakio Foundation.

cyprus-mail.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

Bank of Cyprus is listed as a partner supporting the Foundation's mission.

Strategic tierMinorTypeGTM or Marketing Partner
Description

OPAP Cyprus is listed as a partner supporting the Foundation's charitable mission.

7Leukemia Cancer Society, UK
Strategic tierCoreTypeStrategic or Co-development Partner
Description

One of the co-founders of Karaiskakio Foundation. Dedicated to ensuring that more people with blood cancer survive with the best possible quality of life, and that families and carers get the support they need. Money raised is devoted to recruitment of volunteer bone marrow donors, research, education, and patient care.

karaiskakio.org.cy
8Kemal Saracoglu Association
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Turkish Cypriot NGO that actively supports the Karaiskakio Foundation in contacting donors and serves as a contact point to help Turkish Cypriot patients and physicians access the services of the Foundation. Represents the bi-communal nature of the Cyprus Bone Marrow Donor Registry.

karaiskakio.org.cy
9World Marrow Donor Association (WMDA)
Strategic tierCoreTypeTechnology or Integration
Description

International voluntary network of donor registries and cord blood banks promoting global cooperation in the search for and provision of high quality haematopoietic stem cells. Karaiskakio Foundation has been a member since 2000 and the Cyprus registry was one of the first in the world to be accredited by the agency.

karaiskakio.org.cy
Strategic tierCoreTypeTechnology or Integration
Description

Collaborative effort of stem cell donor registries and cord blood banks providing centralized information on HLA phenotypes and other relevant data of unrelated stem cell donors. All donors in the Cyprus registry are listed in BMDW, enabling patients from around the world to locate matching donors.

11European Federation of Immunogenetics (EFI)
Strategic tierCoreTypeTechnology or Integration
Description

Organization aiming towards the development of Immunogenetics as a subspecialty of laboratory medicine by promoting research and education. The Immunogenetics laboratory of Karaiskakio Foundation has been accredited by EFI since 2004.

karaiskakio.org.cy
12European Leukemia Net
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Organization of physicians, scientists and patients funded by the European Union with interest in the field of leukemia. Aims to improve treatment and knowledge around leukemia in Europe. Karaiskakio Foundation has been an active member since 2008.

karaiskakio.org.cy
13Cyprus Ministry of Health
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborated with the Ministry to establish the Public Rotary Cord Blood Registry in 2005 and provides ongoing support for bone marrow donor registry operations.

karaiskakio.org.cy
14Cyprus Gynaecological Obstetrics Society
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborated with the Foundation to establish the Public Cord Blood Registry in 2005.

karaiskakio.org.cy
15University of Cyprus
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partner collaborating with the Center for the Study of Haematological Malignancies (CSHM) for research purposes.

karaiskakio.org.cy
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partner collaborating with the Center for the Study of Haematological Malignancies (CSHM) for research purposes.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partner collaborating with the Center for the Study of Haematological Malignancies (CSHM) for research purposes.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partner collaborating with the Center for the Study of Haematological Malignancies (CSHM) for research purposes.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partner collaborating with the Center for the Study of Haematological Malignancies (CSHM) for research purposes.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Canada's national blood operator with OneMatch Stem Cell and Marrow Network. Comparable as a non-profit donor registry with HLA typing, cord blood banking, and broader healthcare services beyond what Karaiskakio offers.

TypeDirect peer
Description

Operates the largest bone marrow donor registry in the United States with over 9 million potential donors and is WMDA-accredited. Directly comparable to Karaiskakio as a national bone marrow donor registry with diagnostic facilities and patient services.

TypeDirect peer
Description

UK-based charity operating the world's first bone marrow donor registry with over 900,000 donors. Directly comparable as a non-profit donor registry with research, donor recruitment, and transplantation services.

TypeDirect peer
Description

Israeli non-profit operating one of the largest bone marrow donor registries globally with over 1 million donors. Comparable to Karaiskakio as a non-profit donor registry with international matching capabilities.

TypeDirect peer
Description

German-based global bone marrow donor registry with over 10 million registered donors. Comparable to Karaiskakio as a non-profit international donor registry with WMDA accreditation and donor recruitment focus.

6Eurocord
TypeRegional player
Description

European-based cord blood bank network headquartered in Paris. Comparable to Karaiskakio's cord blood registry operations with similar focus on hematopoietic stem cell sourcing for transplantation.

7NHS Blood and Transplant (NHSBT)
TypeBroad incumbent
Description

UK's national blood, organ, and stem cell donation service with the British Bone Marrow Registry. Comparable as a large-scale donor registry with diagnostic capabilities and government affiliation.

8Federation of European Cancer Societies (FECS) - Leukemia Section
TypeOthers
Description

European-level cancer and leukemia research/policy organization. Comparable to Karaiskakio's research and policy engagement activities through the Center for the Study of Haematological Malignancies and European Leukemia Net membership.

TypeDirect peer
Description

Canadian provincial blood and stem cell operator managing donor registries, cord blood banking, and specialized diagnostic labs. Comparable to Karaiskakio's combination of donor registry, cord blood banking, and diagnostic services.

TypeDirect peer
Description

US-based non-profit operating an accredited bone marrow and stem cell donor registry with donor recruitment and transplant facilitation services. Closely comparable to Karaiskakio in mission and operating model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Karaiskakio Foundation

Non-profit Hematology and Bone Marrow Registry Serviceskaraiskakio.org.cy

Karaiskakio Foundation is a Cyprus-based non-profit operating the world's largest per capita bone marrow donor registry (200,000+ donors), four EFI/WMDA-accredited diagnostic laboratories, a cord blood registry, and pediatric rare disease services, serving patients with hematological malignancies at no cost.

What Karaiskakio Foundation does

Karaiskakio Foundation is a Cyprus-based non-profit charitable organization founded in 1996 in memory of Andreas Karaiskakis, a 5-year-old who died of leukemia after a matching bone marrow donor could not be found. The Foundation operates the Cyprus Bone Marrow Donor Registry — recognized as the world's largest per capita with over 200,000 registered Greek-Cypriot and Turkish-Cypriot volunteer donors — along with the Public Rotary Cord Blood Registry (4,500+ stored units) and a network of four specialized diagnostic laboratories: an Immunogenetics Laboratory (continuously EFI-accredited since 2004), an eight-color Flow Cytometry Laboratory serving as Cyprus's central reference lab for hematological malignancies, a Molecular Haematology Laboratory, and a CytoGenomics Laboratory employing SKY-FISH and Microarray methodologies. The Foundation also runs the Center for the Study of Haematological Malignancies (CSHM/KEMAK, established 2008) as its research arm and the Care for Rare Clinic for pediatric genetic disorders, and it offers a Hair Donation Program in partnership with Wigs for Kids.

Services are delivered at no cost to patients; the Foundation funds donor search, tissue typing (€40 per new donor typing), and diagnostic testing through a diversified revenue model comprising individual donations, membership subscriptions (€20/year plus €10 registration), Cyprus Ministry of Health government sponsorship, corporate sponsorships via the 'Partnership 4 Life' CSR program, and fees from specialized diagnostic services. Distribution combines a hospital blood bank collection network across Cyprus, the global Bone Marrow Donors Worldwide (BMDW) integration (member since 2000), a Nicosia General Hospital on-site presence, and an online donor registration portal.

Operationally, the Foundation has facilitated over 950 bone marrow transplants across 36 countries and served 30,000+ patients with diagnostic tests. It is governed by an unpaid Board appointed by its co-founders (Cyprus Ministry of Health, Association of Friends of Karaiskakio Foundation, the Karaiskakis family, and the UK Leukemia Cancer Society), with a workforce of 11–50 employees based at its Nicosia headquarters.

Karaiskakio Foundation firmographics

Firmographics
Name
Karaiskakio Foundation
Legal name
Karaiskakio Foundation
Website
https://karaiskakio.org.cy
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
11–50 employees
Short description
Karaiskakio Foundation is a Cyprus-based non-profit operating the world's largest per capita bone marrow donor registry (200,000+ donors), four EFI/WMDA-accredited diagnostic laboratories, a cord blood registry, and pediatric rare disease services, serving patients with hematological malignancies at no cost.
Ownership category
akta.pro rank

Karaiskakio Foundation industry classification

Industry
Product category
Non-profit Hematology and Bone Marrow Registry Services
NAICS
Blood and Organ Banks (621991), Voluntary Health Organizations (813212)
SIC
Services-Medical Laboratories (8071), Services-Social Services (8300)
akta.pro industry
PRIMARYBPAGACAJ
Blood, Organ & Tissue Donation Organizations
SECONDARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking

Keywords

  • Bone marrow registry
  • Hematology diagnostic services
  • Cord blood banking
  • Leukemia transplant support
  • Rare disease genetics

Where Karaiskakio Foundation is headquartered

Location

Headquarters

HQ city
Nicosia
HQ country
Cyprus
HQ region
Europe

Offices1 record

Markets served

Karaiskakio Foundation business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

  1. Donations and Contributions: The Foundation relies heavily on donations from individuals, companies, and organizations. Donations can be general or for specific purposes (in memory of someone, in honor of celebrations, wedding/christening gifts, etc.). A donation of €40 can finance tissue typing of a new bone marrow donor volunteer.
  2. Membership Fees: Annual membership subscription of €20 with a registration fee of €10 for new members. Members have voting rights and can be candidates for the Volunteer Member Council.
  3. Government Sponsorship: Government sponsorship for support of the Cyprus Donor Registry. The Ministry of Health collaborates with the Foundation on various programs.
  4. Corporate Sponsorships (Partnership 4 Life): Corporate partnerships through the 'Partnership 4 Life' program where companies support the Foundation's mission as part of their Corporate Social Responsibility. Sponsors provide financial support in exchange for association with the Foundation's humanitarian work.
  5. Service Revenue: Income from provision of specialized diagnostic laboratory services. The Foundation aims to serve needs of patients with haematological malignancies efficiently and effectively without financial burden to patients or families.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualMembership subscription
Donation/ grant-fundedOne-timeDonor tissue typing sponsorship
OtherOne-timeFundraising event tickets

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Karaiskakio Foundation product offering

Product offering

Core offering

Karaiskakio Foundation operates the Cyprus Bone Marrow Donor Registry — the world's largest per capita with over 200,000 registered donors — along with a Public Cord Blood Registry, four EFI/WMDA-accredited diagnostic laboratories (Immunogenetics, Flow Cytometry, Molecular Haematology, CytoGenomics), the Care for Rare Clinic for pediatric genetic disorders, and the CSHM research center. All donor search, tissue typing, and diagnostic services are provided to patients free of charge, funded by donations, government sponsorship, corporate partnerships, and membership fees.

Product overview

Karaiskakio Foundation is a non-profit organization operating as a comprehensive healthcare center focused on haematological malignancies and related diseases. The foundation operates its core services through the Cyprus Bone Marrow Donor Registry (one of the world's largest per capita registries with over 200,000 donors), the Cyprus Rotary Cord Blood Registry, and a network of four specialized diagnostic laboratories (Immunogenetics, Flow Cytometry, Molecular Haematology, and CytoGenomics). The foundation also conducts research through its Center for the Study of Haematological Malignancies (CSHM/KEMAK), operates the Care for Rare Clinic for pediatric genetic disorders, and offers community services including a hair donation program and online donation platform. Services are provided free of charge to patients, with the foundation covering all costs for donor searches and laboratory testing.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cyprus Bone Marrow Donor Registry Operates the world's largest per capita bone marrow donor registry with over 200,000 registered Greek Cypriot and Turkish Cypriot volunteer donors; accredited by WMDA since 2008 and connected to Bone Marrow Donors Worldwide. Facilitates donor searches for patients with leukemia and other hematological malignancies free of charge.
  • Cyprus Rotary Cord Blood Registry Public cord blood registry established in collaboration with the Cyprus Ministry of Health and ten Rotary Clubs, storing over 4,500 cord blood units as an alternative stem cell source for transplant patients. Currently focuses on directed and autologous donations as new public storage is no longer accepted.
  • Immunogenetics Laboratory Services EFI-accredited laboratory since 2004 providing tissue typing and HLA compatibility testing for bone marrow donor matching. Provides state-of-the-art immunogenetics testing to support transplant matching for patients with hematological malignancies.
  • Flow Cytometry Laboratory Services Eight-color flow cytometry laboratory serving as the central reference laboratory for hematological malignancies diagnostics in Cyprus. Responsible for diagnosis and monitoring of disease burden in leukemia, lymphoma, and other blood cancers.
  • Molecular Haematology Laboratory Services Specialized molecular testing for detection of recurrent chromosomal aberrations and gene mutations affecting prognosis of leukemias. Includes thrombophilia and hemophilia tests, supporting detailed evaluation of therapy options and timely detection of disease relapse.
  • CytoGenomics Laboratory Services Combines classical cytogenetics and modern cytogenomics methodologies including SKY-FISH and Microarray for studying hematological malignancies. Supports diagnosis, prognosis, and monitoring of blood cancers.
  • Care for Rare Clinic Integrated interdisciplinary centre for children and families with rare diseases and genetic disorders, providing holistic disease management and pediatric genetic testing services. Has supported more than 30,000 patients with specialized diagnostics.
  • Hair Donation Program Community program collecting hair donations in partnership with Wigs for Kids to support children who have lost their hair due to leukemia, cancer, or other disease treatments.
  • Online Donation Platform Digital donation platform enabling individuals and organizations to contribute financially to support the Foundation's activities and patient services. A donation of €40 can finance the tissue typing of one new bone marrow donor volunteer.
  • Center for the Study of Haematological Malignancies (CSHM/KEMAK) Non-profit research arm of the Foundation established in 2008, conducting studies on hematological malignancies in collaboration with University of Cyprus, University of Cambridge, University of Surrey, University of Athens, and University of Patras.

Quantifiable outcome

  • Over 950 life-saving bone marrow transplants facilitated across 36 countries and 5 continents
  • +4 more outcomes

Companies that use Karaiskakio Foundation

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Karaiskakio Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Karaiskakio Foundation partnerships and signals

Strategic signal

Partnerships

19 partnerships are on record, tiered core and minor.

  • Allwyn CypruscoreStrategic or Co-development Partner · 14 July 2026Allwyn Cyprus unveiled the 'Allwyn Care' healthcare initiative in collaboration with Karaiskakio Foundation and other healthcare organizations including PASYKAF, Europa Donna Cyprus, and Europa Uomo Cyprus. The program supports cancer awareness, early diagnosis, bone marrow donor registry development, and palliative care services, reaching over 250,000 people through awareness campaigns.
  • EurolifecoreStrategic or Co-development Partner · 7 November 2025Eurolife and Karaiskakio Foundation formalized a strategic partnership aimed at strengthening the Foundation's research and educational work while promoting volunteerism and social contribution among Cyprus' younger generation. The collaboration falls within Eurolife's Corporate Social Responsibility framework, reflecting shared values of supporting life, health, and hope.
  • Lexus Cycling Dream TeamminorGTM or Marketing Partner · 20 October 2025The Lexus Cycling Dream Team, a group of Cypriot business executives passionate about cycling and philanthropy, organized the 'Ride of Love 2025' charity cycling event covering 175 kilometers across Cyprus, supporting the Childhood Cancer Diagnostic and Investigation Centre of the Karaiskakio Foundation.
  • KINTO EuropeminorGTM or Marketing Partner · 20 October 2025KINTO Europe (Toyota Motor Europe's subsidiary) served as Mobility Partner for the 'Ride of Love 2025' cycling event supporting Karaiskakio Foundation.
  • Bank of CyprusminorGTM or Marketing PartnerBank of Cyprus is listed as a partner supporting the Foundation's mission.
  • OPAP CyprusminorGTM or Marketing PartnerOPAP Cyprus is listed as a partner supporting the Foundation's charitable mission.
  • Leukemia Cancer Society, UKcoreStrategic or Co-development PartnerOne of the co-founders of Karaiskakio Foundation. Dedicated to ensuring that more people with blood cancer survive with the best possible quality of life, and that families and carers get the support they need. Money raised is devoted to recruitment of volunteer bone marrow donors, research, education, and patient care.
  • Kemal Saracoglu AssociationcoreStrategic or Co-development PartnerTurkish Cypriot NGO that actively supports the Karaiskakio Foundation in contacting donors and serves as a contact point to help Turkish Cypriot patients and physicians access the services of the Foundation. Represents the bi-communal nature of the Cyprus Bone Marrow Donor Registry.
  • World Marrow Donor Association (WMDA)coreTechnology or IntegrationInternational voluntary network of donor registries and cord blood banks promoting global cooperation in the search for and provision of high quality haematopoietic stem cells. Karaiskakio Foundation has been a member since 2000 and the Cyprus registry was one of the first in the world to be accredited by the agency.
  • Bone Marrow Donors Worldwide (BMDW)coreTechnology or IntegrationCollaborative effort of stem cell donor registries and cord blood banks providing centralized information on HLA phenotypes and other relevant data of unrelated stem cell donors. All donors in the Cyprus registry are listed in BMDW, enabling patients from around the world to locate matching donors.
  • European Federation of Immunogenetics (EFI)coreTechnology or IntegrationOrganization aiming towards the development of Immunogenetics as a subspecialty of laboratory medicine by promoting research and education. The Immunogenetics laboratory of Karaiskakio Foundation has been accredited by EFI since 2004.
  • European Leukemia NetminorStrategic or Co-development PartnerOrganization of physicians, scientists and patients funded by the European Union with interest in the field of leukemia. Aims to improve treatment and knowledge around leukemia in Europe. Karaiskakio Foundation has been an active member since 2008.
  • Cyprus Ministry of HealthcoreStrategic or Co-development PartnerCollaborated with the Ministry to establish the Public Rotary Cord Blood Registry in 2005 and provides ongoing support for bone marrow donor registry operations.
  • Cyprus Gynaecological Obstetrics SocietyminorStrategic or Co-development PartnerCollaborated with the Foundation to establish the Public Cord Blood Registry in 2005.
  • University of CyprusminorStrategic or Co-development PartnerAcademic partner collaborating with the Center for the Study of Haematological Malignancies (CSHM) for research purposes.
  • University of CambridgeminorStrategic or Co-development PartnerAcademic partner collaborating with the Center for the Study of Haematological Malignancies (CSHM) for research purposes.
  • University of SurreyminorStrategic or Co-development PartnerAcademic partner collaborating with the Center for the Study of Haematological Malignancies (CSHM) for research purposes.
  • University of AthensminorStrategic or Co-development PartnerAcademic partner collaborating with the Center for the Study of Haematological Malignancies (CSHM) for research purposes.
  • University of PatrasminorStrategic or Co-development PartnerAcademic partner collaborating with the Center for the Study of Haematological Malignancies (CSHM) for research purposes.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Karaiskakio Foundation competitors and assessment

Company assessment

Broad incumbents

  • Canadian Blood Services: Canada's national blood operator with OneMatch Stem Cell and Marrow Network. Comparable as a non-profit donor registry with HLA typing, cord blood banking, and broader healthcare services beyond what Karaiskakio offers.
  • NHS Blood and Transplant (NHSBT): UK's national blood, organ, and stem cell donation service with the British Bone Marrow Registry. Comparable as a large-scale donor registry with diagnostic capabilities and government affiliation.

Direct peers

  • Be The Match (National Marrow Donor Program): Operates the largest bone marrow donor registry in the United States with over 9 million potential donors and is WMDA-accredited. Directly comparable to Karaiskakio as a national bone marrow donor registry with diagnostic facilities and patient services.
  • Anthony Nolan: UK-based charity operating the world's first bone marrow donor registry with over 900,000 donors. Directly comparable as a non-profit donor registry with research, donor recruitment, and transplantation services.
  • Ezer Mizion Bone Marrow Donor Registry: Israeli non-profit operating one of the largest bone marrow donor registries globally with over 1 million donors. Comparable to Karaiskakio as a non-profit donor registry with international matching capabilities.
  • DKMS: German-based global bone marrow donor registry with over 10 million registered donors. Comparable to Karaiskakio as a non-profit international donor registry with WMDA accreditation and donor recruitment focus.
  • Héma-Québec: Canadian provincial blood and stem cell operator managing donor registries, cord blood banking, and specialized diagnostic labs. Comparable to Karaiskakio's combination of donor registry, cord blood banking, and diagnostic services.
  • Gift of Life Bone Marrow Foundation: US-based non-profit operating an accredited bone marrow and stem cell donor registry with donor recruitment and transplant facilitation services. Closely comparable to Karaiskakio in mission and operating model.

Regional players

  • Eurocord: European-based cord blood bank network headquartered in Paris. Comparable to Karaiskakio's cord blood registry operations with similar focus on hematopoietic stem cell sourcing for transplantation.

Others

  • Federation of European Cancer Societies (FECS) - Leukemia Section: European-level cancer and leukemia research/policy organization. Comparable to Karaiskakio's research and policy engagement activities through the Center for the Study of Haematological Malignancies and European Leukemia Net membership.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Karaiskakio Foundation social profiles

Digital presence

Karaiskakio Foundation compliance and trust

Trust signal

Compliance2 records

Karaiskakio Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Karaiskakio Foundation leadership team

Management profile

Number of profiles

Profiles13 records

Karaiskakio Foundation subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Karaiskakio Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Karaiskakio Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Karaiskakio Foundation

What does Karaiskakio Foundation do?

Karaiskakio Foundation operates the Cyprus Bone Marrow Donor Registry — the world's largest per capita with over 200,000 registered donors — along with a Public Cord Blood Registry, four EFI/WMDA-accredited diagnostic laboratories (Immunogenetics, Flow Cytometry, Molecular Haematology, CytoGenomics), the Care for Rare Clinic for pediatric genetic disorders, and the CSHM research center. All donor search, tissue typing, and diagnostic services are provided to patients free of charge, funded by donations, government sponsorship, corporate partnerships, and membership fees.

Is Karaiskakio Foundation a public or private company?

Karaiskakio Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Karaiskakio Foundation founded?

Karaiskakio Foundation was founded in 1996. It employs 11 to 50 people.

Where is Karaiskakio Foundation based?

Karaiskakio Foundation is headquartered in Nicosia, Cyprus, in the Europe region.

How does Karaiskakio Foundation make money?

Five revenue lines are on record. Donations and Contributions are the primary driver. The others are membership Fees, government Sponsorship, corporate Sponsorships (Partnership 4 Life) and service Revenue.

Who are Karaiskakio Foundation's main competitors?

Broad incumbents on record are Canadian Blood Services and NHS Blood and Transplant (NHSBT). Direct peers are Be The Match (National Marrow Donor Program), Anthony Nolan, Ezer Mizion Bone Marrow Donor Registry, DKMS, Héma-Québec and Gift of Life Bone Marrow Foundation. Eurocord is listed as a regional player. Federation of European Cancer Societies (FECS) - Leukemia Section is listed as an others.

Does Karaiskakio Foundation have an API?

No public API is recorded for Karaiskakio Foundation.

What industry is Karaiskakio Foundation in?

Karaiskakio Foundation's product category is Non-profit Hematology and Bone Marrow Registry Services. Its primary akta.pro industry code is BPAGACAJ, Blood, Organ & Tissue Donation Organizations, with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 621991 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Cyprus MailEverybody Falls follows Cyprus biker’s journey to the summitA documentary follows Cypriot downhill biker Savvina Koulle from her training to winning the icy Mountain of Hell race in France in 2025. The film promotes resilience and bone marrow donor registration, with all net proceeds donated to the Karaiskakio Foundation. It will screen at Premier Cinemas in Nicosia on November 17.Cyprus MailLexus Cycling Dream Team honoured for 2025 Ride of Love contributionThe Lexus Cycling Dream Team was honoured at the Karaiskakio Foundation's 30th anniversary event on September 23, 2026, for its Ride of Love 2025 contribution. The team raised and donated €25,000 to support the Paediatric Cancer Centre's screening and diagnostic programme. The team will ride again on November 6-7, 2026, for Ride of Love 2026.Cyprus MailCyprus boasts over 200,000 bone marrow donorsThe Karaiskakio Foundation reported over 205,400 registered bone marrow donors and more than 1,000 transplants to patients in 36 countries on World Marrow Donor Day. The foundation noted that over 70,000 patients seek donors outside family each year, with half finding compatible donors abroad.Cyprus MailKaraiskakio to mark 30 years of science, giving at 2026 European Researchers’ NightThe Karaiskakio Foundation will participate in European Researchers' Night 2026 on September 25, 2026, at the Cyprus State Fairgrounds in Nicosia. It will host interactive activities on bone marrow and organ donation, including a DNA matching game, marking 30 years of its service.Cyprus MailBean Bar joins forces with Karaiskakio Foundation in fight against leukaemiaBean Bar will donate all net proceeds from its RCVRY Sol juice sales to the Karaiskakio Foundation during World Leukaemia Awareness Month in September 2026. The foundation supports patients with leukaemia and other haematological malignancies in Cyprus and abroad. Bean Bar cups will feature special designs to raise awareness.Cyprus MailKaraiskakio Foundation to hold glamorous ‘Dinner for Life’ fundraiserThe Karaiskakio Foundation announced its 'Dinner For Life' fundraising event to be held on September 12, 2026, at Paphos Town Hall in Cyprus, marking 30 years of continuous service to support its Paediatric Cancer Screening and Diagnosis Programme. The Foundation operates one of the world's largest bone marrow donor registries per capita, with nearly one in four Cypriots registered as volunteer donors, and has facilitated life-saving procedures for over 950 patients across 36 countries. The charity dinner will feature performances by Constantinos Christoforou and the band ONE, with tickets priced at €80.Cyprus MailAllwyn Care: more care for all through meaningful health initiativesAllwyn Cyprus unveiled a series of healthcare initiatives under its Allwyn Care program at the Nicosia Municipal Theatre on July 14, 2026, in collaboration with healthcare organizations including PASYKAF, Karaiskakio Foundation, Europa Donna Cyprus, and Europa Uomo Cyprus. The program supports cancer awareness, early diagnosis, bone marrow donor registry development, and palliative care services, reaching over 250,000 people through awareness campaigns and providing thousands of medical consultations and free specialized sessions annually. The initiative aims to create a comprehensive platform for supporting public health in Cyprus through prevention, early diagnosis, and community engagement.Cyprus MailKaraiskakio honoured at 2026 ESQR Quality Achievements Awards in BrusselsThe Karaiskakio Foundation received international recognition at the ESQR Quality Achievements Awards 2026 in Brussels. The award highlights its ISO 15189 and ISO 9001 accreditations and its role in healthcare and research. The Foundation continues to invest in knowledge and international partnerships.Cyprus MailKaraiskakio, Ayia Napa Marina to hold third edition of ‘Glowmorous Dinner’The Karaiskakio Foundation and Ayia Napa Marina will host the third Glowmorous Dinner on July 3, 2026, at the Marina's Event Center. The charity gala supports the foundation's pediatric cancer program, with tickets priced at €125 and a live performance by Peggy Zina.Cyprus MailEurolife and Karaiskakio Foundation announce strategic partnershipEurolife has entered a strategic partnership with the Karaiskakio Foundation in Cyprus, aiming to bolster the foundation's research and educational work while cultivating values of volunteerism and social contribution among Cyprus' younger generation. The collaboration falls within Eurolife's Corporate Social Responsibility framework and reflects the company's stated values of supporting life, health, and hope. Both organizations described the partnership as a milestone that will empower the foundation's ongoing mission.